Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., . . . Nikiforov, Y. E. (2005). Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. American Society for Clinical Investigation.
Citación estilo ChicagoCiampi, Raffaele, Jeffrey A. Knauf, Roswitha Kerler, Manoj Gandhi, Zhaowen Zhu, Marina N. Nikiforova, Hartmut M. Rabes, James A. Fagin, y Yuri E. Nikiforov. Oncogenic AKAP9-BRAF Fusion Is a Novel Mechanism of MAPK Pathway Activation in Thyroid Cancer. American Society for Clinical Investigation, 2005.
Cita MLACiampi, Raffaele, et al. Oncogenic AKAP9-BRAF Fusion Is a Novel Mechanism of MAPK Pathway Activation in Thyroid Cancer. American Society for Clinical Investigation, 2005.